Avinger (NASDAQ: AVGR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.170 | -2.330 | -1.1600 | ||||
REV | 2.050M | 1.888M | -162.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Avinger (NASDAQ: AVGR) through any online brokerage.
Other companies in Avinger’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Aethlon Medical (NASDAQ:AEMD), Motus GI Hldgs (NASDAQ:MOTS), Medigus (NASDAQ:MDGS) and Viveve Medical (NASDAQ:VIVE).
The latest price target for Avinger (NASDAQ: AVGR) was reported by B. Riley Securities on Friday, March 18, 2022. The analyst firm set a price target for 11.00 expecting AVGR to rise to within 12 months (a possible 638.26% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Avinger (NASDAQ: AVGR) is $1.49 last updated Today at July 6, 2022, 5:15 PM UTC.
There are no upcoming dividends for Avinger.
Avinger’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Avinger.
Avinger is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.